共 59 条
[1]
Silberstein SD(2000)Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 55 754-762
[2]
Becker WJ(2015)Acute migraine treatment in adults Headache 55 778-793
[3]
Marmura MJ(2015)The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies Headache 55 3-20
[4]
Silberstein SD(2007)Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden Headache 47 475-479
[5]
Schwedt TJ(2006)Acute migraine treatment: patterns of use and satisfaction in a clinical population Headache 46 773-780
[6]
Bigal M(2014)Identifying the factors underlying discontinuation of triptans Headache 54 278-289
[7]
Rapoport A(2018)Triptan use and discontinuation: results from the MAST study Neurol Rev 26 30-1311
[8]
Aurora S(2013)Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study Headache 53 1300-1521
[9]
Sheftell F(2017)Framingham-based cardiovascular risk estimates among people with episodic migraine in the US population: results from the American Migraine Prevalence and Prevention (AMPP) Study Headache 57 1507-1168
[10]
Tepper S(2008)Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study Headache 48 1157-649